On Sunday, Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that the FDA has placed a clinical hold on its prospective Phase 3 pivotal trial evaluating …
Inovio Pharmaceuticals Inc (NASDAQ:INO) investors are having a rough day after the cancer vaccine maker announced that the FDA has placed a clinical hold on its proposed …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced strategic leadership appointments to support the advancement of its portfolio of DNA-based cancer immunotherapies and infectious disease vaccines. Inovio …
In a research report released Tuesday, Brean Capital analyst Jason Wittes assumed coverage on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), with a Buy rating …
Maxim analyst Jason McCarthy weighed in with a few insights on Inovio Pharmaceuticals Inc (NASDAQ:INO), after the company announced that the phase I study …
Inovio Pharmaceuticals Inc (NASDAQ:INO) posted second-quarter financial results on Monday. With pipeline drug approval within reach, a new Phase 3 study starting soon, …
In a research note issued yesterday, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) with a price target of …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its novel DNA-based monoclonal antibody technology will be deployed to develop products which could be used alone and …
Following an announcement that the FDA granted approval to initiate a Phase 1 trial of Zika drug GLS-5700, analyst Ram Selvaraju of Rodman & …
Maxim analyst Jason McCarthy weighed in today with a few insights on Inovio Pharmaceuticals Inc (NASDAQ:INO), following the news that the company’s Zika vaccine candidate, GLS-5700, …
